{"id":"tp-52121","type":"article-newspaper","title":"Novartis Is Largely Abandoning Ionis Heart Drug After Trial Failure","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/52121","datePublished":"2026-11-09T06:58:02.000Z","dateModified":"2026-11-09T06:58:02.000Z","language":"en","abstract":"The RNA-targeting candidate failed in a late-stage trial last September.","section":"Business","references":[]}